How long does Gonadorelin stay in your system?
Gonadorelin has a published half-life of 2 to 4 minutes. By the standard pharmacology rule of thumb, a drug is about 97% eliminated after roughly five half-lives, which here works out to between 10 and 20 minutes. The figure describes natural GnRH, which gonadorelin is identical to.
Source: Lee & Kelly, F&S Reports 2023 (PMC10201293) · Review article · measured: intravenous · dataset reviewed September 23, 2026
What is the half-life of Gonadorelin?
Gonadorelin's half-life of 2 to 4 minutes after intravenous administration comes from a 2023 review in F&S Reports. Strictly, the figure describes endogenous gonadotropin-releasing hormone, GnRH. Gonadorelin is the identical synthetic decapeptide, so the value transfers, but it is not a measurement of a gonadorelin product.
A short half-life fits how GnRH works. The hypothalamus releases it in pulses, and brief, intermittent exposure sustains the pituitary's release of LH and FSH, while continuous exposure desensitises the receptor and suppresses it. A hormone that clears in minutes lets each pulse register as a distinct signal.
How much Gonadorelin is left after each half-life?
Each half-life removes half of whatever is left, so the percentages are pure arithmetic and the same for any compound; only the clock changes. For Gonadorelin, one half-life is 2 to 4 minutes. The rows below run that forward for a single amount with nothing added.
| Half-lives elapsed | Time elapsed | Remaining | Cleared |
|---|---|---|---|
| 1 | 2 to 4 minutes | 50% | 50% |
| 2 | 4 to 8 minutes | 25% | 75% |
| 3 | 6 to 12 minutes | 12.5% | 87.5% |
| 4 | 8 to 16 minutes | 6.25% | 93.75% |
| 5 | 10 to 20 minutes | 3.13% | 96.88% |
| 6 | 12 to 24 minutes | 1.56% | 98.44% |
| 7 | 14 to 28 minutes | 0.78% | 99.22% |
Why do the numbers differ between sources?
Gonadorelin figures vary partly because so few measurements of the product exist. The human Factrel product is discontinued, and the surviving DailyMed entry is a veterinary label with no pharmacokinetics section. That leaves the endogenous hormone as the best available reference.
Compounded gonadorelin, the main route of present-day human access, carries no label pharmacokinetics of its own. Formulation and route can change how quickly a peptide is absorbed, so a figure for intravenous GnRH cannot be assumed to describe a compounded product given another way.
What does a half-life not tell you?
The half-life tells you gonadorelin itself is gone within minutes. It does not tell you how long the LH and FSH it releases stay elevated, or how long the downstream testosterone or estrogen response lasts. Those hormones follow their own kinetics, set by the pituitary and the gonads rather than by gonadorelin.
It also cannot capture the difference between pulsatile and continuous exposure, which decides whether the reproductive axis is stimulated or suppressed. That is a property of the pattern of exposure, not of the half-life.
Can you run the numbers yourself?
The estimator applies the same decay arithmetic to any half-life, starting amount and time you enter. It opens with Gonadorelin's published value loaded. Type another figure to see how sensitive the result is to it.
Published value: 2 to 4 minutes (Intravenous) · Lee & Kelly, F&S Reports 2023 (PMC10201293) · Compound profile
Show the math
What are the limits of this estimate?
Everything above is a single-compartment approximation: one pool of drug, falling by the same fraction in every interval. Real elimination varies with kidney and liver function, body composition, formulation and route, and a published figure describes only the route and the people it was measured in. Many compounds also show a fast distribution phase before the slower elimination the table describes.
A half-life is not a dosing schedule. Labelled intervals come from clinical trials that measured outcomes and tolerability, and nothing on this page suggests when to take, repeat or stop anything. Whether Gonadorelin is out of your system for drug-testing purposes is a different question again. Tests often look for metabolites rather than the parent compound, and the answer depends on the assay, its sensitivity and the sample type, none of which a plasma half-life captures.
FAQ.
Is the gonadorelin half-life measured on the drug itself?
No. The 2 to 4 minute figure describes endogenous GnRH. Gonadorelin is the identical synthetic decapeptide, so the value transfers, but no current human product label provides a measurement of its own. The human Factrel product is discontinued.
Does gonadorelin stay in the body as long as the hormones it releases?
No. Gonadorelin is cleared within minutes, while the LH and FSH it prompts the pituitary to release, and the sex hormones produced downstream, follow their own slower kinetics. Gonadorelin's half-life describes only gonadorelin.
Is gonadorelin the same as a long-acting GnRH agonist?
No. Gonadorelin is identical to natural GnRH and clears in minutes. Long-acting GnRH agonists are modified molecules built for continuous exposure, which suppresses rather than stimulates the reproductive axis. Their pharmacokinetics are different and are not covered here.
For what the evidence on Gonadorelin actually shows, read the Gonadorelin profile. For approval and regulatory position, see is Gonadorelin legal. The half-life reference lists every sourced value side by side, including the compounds where a number circulates online with no reliable human data behind it.